RESEARCH SUPPORT, NON-U.S. GOV'T
Add like
Add dislike
Add to saved papers

Colour Doppler sonography: a new investigative modality for intraocular space-occupying lesions.

Eye 1994
We report our experience with colour Doppler sonography (CDS) in 20 normal subjects and 25 patients with intraocular space-occupying lesions. The technique provided an in vivo cross-section of the vascular topography of space-occupying lesions in real time. Colour coding and spectral analysis helped to determine the direction and pattern of blood flow. CDS was found to be a useful diagnostic adjuvant, a guide to the treatment protocol, and helped in monitoring the progress of the disease. In conditions of the eye where unclear media hindered a clinical evaluation, CDS sonography was a safe, easily reproducible and non-invasive investigative tool. With further technical advances in waveform analysis and quantitative assessment, CDS holds promise as an investigative modality of choice in the future.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app